Tuesday, November 5, 2024
The stock market offers pockets of opportunity in sectors that combine a decent dividend yield with a good quality business. In other words, growth and income. One such sector is the pharmaceuticals sector, which overall has lagged the S&P 500 in the past five years, although not by much. There are, no doubt, some world-class […]
The pharma giant GSK PLC (GSK) is working to emerge from years with a share price that goes nowhere. The company’s CEO, Emma Walmsley, is still trying to convince investors that she is delivering a “new chapter of growth” after many years of underperformance. GSK shares are down 3% over the past five years, while […]
I continue to maintain that the 2023 stock market will look a lot like the 2022 stock market. Big tech continues to reel from overspending during the pandemic, and are being forced to fire large numbers of employees to cut costs. Meanwhile, America’s more traditional mid-cap companies in dull sectors like manufacturing—which have had to […]
As the emerging world’s economies grow and become more developed, healthcare professionals are worried about an unpleasant side effect. Whenever populations’ dietary habits change amid economic growth, more and more people are become overweight. This, in turn, leads to a dramatic rise in cases of diabetes. But there’s hope on the horizon for those suffering […]
Founded in 1923, Novo Nordisk (NVO) is a global healthcare company headquartered in Denmark. Its focus is on diabetes and other serious chronic conditions, such as obesity, as well as rare blood and endocrine diseases. The company is the global powerhouse in diabetes treatment, with about 30% of the $50+ billion global diabetes market and […]
If there is one topic that scientists disagree strongly about in the field of medicine, it is the so-called amyloid hypothesis. This theory, believed by many scientists, holds that the protein amyloid-β accumulates into toxic deposits as Alzheimer’s disease progresses, ultimately causing dementia. However, others think that amyloid is associated with the problem, but it […]
Few sectors can withstand the economic headwinds that come during periods of economic upheaval, including recession and inflation. Recession stocks are sought out by retail and institutional investors alike. But one sector that can thrive is food—people will always need to eat. Another area largely insulated from market turmoil is the pharmaceutical sector. Prescription drugs […]
Just when you thought it was safe to go outside, monkeypox pops up. “Doctors warned that numbers will rise significantly as the virus spreads through Europe and as far as the U.S., Canada, and Australia. Spain now has the highest number of infections, outside places in Africa where the virus is endemic, with more than […]
For well over 20 years, shareholders of GlaxoSmithKline PLC (GSK) have been on a long journey to nowhere, with the pharmaceutical company lagging well behind its peers. That’s why activist investor Elliott Management has been pushing the company to come up with a plan to correct years of stock price underperformance and operational drift. The […]
Vaccine makers’ stocks are soaring. Pfizer (PFE) was up $1.75 earlier this week, at $52.00 BioNTech (BNTX) was up about $17, at $152.40 Moderna (MRNA)was up $15, at $153.25 This is due in part to news that China is battling another wave of coronavirus infections. Millions of people across China are on lockdown. Schools in […]
